Gallacher Capital Management LLC raised its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 11.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,511 shares of the company’s stock after buying an additional 987 shares during the period. Gallacher Capital Management LLC’s holdings in Colgate-Palmolive were worth $865,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in the business. Chicago Partners Investment Group LLC raised its holdings in Colgate-Palmolive by 16.2% in the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after acquiring an additional 943 shares during the period. Peak Financial Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth $1,315,000. Fiduciary Alliance LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $4,066,000. Impact Partnership Wealth LLC bought a new position in Colgate-Palmolive during the fourth quarter worth about $803,000. Finally, Barclays PLC raised its stake in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after purchasing an additional 2,132,747 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Stock Performance
NYSE:CL opened at $89.80 on Friday. The stock has a market cap of $72.87 billion, a P/E ratio of 25.51, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The stock’s 50-day moving average is $89.02 and its 200-day moving average is $94.74. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30.
Analyst Upgrades and Downgrades
Several research analysts have recently commented on CL shares. Stifel Nicolaus lowered their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a report on Monday, February 3rd. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Royal Bank of Canada restated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. JPMorgan Chase & Co. raised their price objective on Colgate-Palmolive from $97.00 to $99.00 and gave the stock an “overweight” rating in a research note on Friday. Finally, Raymond James restated an “outperform” rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $101.72.
View Our Latest Research Report on Colgate-Palmolive
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Golden Cross Stocks: Pattern, Examples and Charts
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.